BioClinica said the new EDA will collect planning information from all of Millennium’s Optimizer-simulated protocols in a central repository and provide an enterprise-wide view of the demand over time.
Millennium is using its Optimizer since 2007 for the improving its ability to forecast clinical trial supplies and simulate studies’ requirements.
BioClinica eClinical Solutions president Peter Benton said the pharmaceutical industry relies on technology innovation to drive necessary efficiencies and the partnership demonstrates Millennium’s commitment to innovate while also validating the benefits that BioClinica’s Optimizer technology provides.